DCE—MRI对局部进展期乳腺癌新辅助化疗的临床指导价值研究(3)
[2]Sobin LH，Gospodarowicz MK，Wittekind C.TNM Classification of Malignant Tumours，7th edn[M].NEW YORK：Wiley-Black-well，2009.
[3]Fisher B，Brown A，Mamounas E，et al.Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer：findings from National Surgical Adjuvant Breast and Bowel Project B-18[J].Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology，1997，15(7)：2483-2493.
, 百拇医药
[4]van der H age JA，van de V elde CJ，Julien JP，et al.Preoperative chemotherapy in primary operable breast cancer：results from the European Organization for research and treatment of cancer trial10902[J].JC lin O ncol，2001，19(22)：4224-4237.
[5]Londero V，Bazzocchi M，D elFrate C，et al.Locally advanced breast cancer：comparison of m am m ography，sonography and M R im aging in evaluation of residual disease in women receiving neoadjuvant chemotherapy[J].Eur R adiol，2004，14(8)：1371-1379.
, 百拇医药
[6]Kuhl C K，Mielcareck P，Klaschik S，et al.Dynamic breast MR imaging：are signal intensity time course data useful for differential diagnosis of enhancing lesions[J].Radiology，1999，211(1)：101.
[7]王丽，仁友，蒋涛.乳腺疾病动态增强MRI半定量参数与微血管密度的相关性[J].中国医学影像技术，2007，23(3)：388-392.
[8]Rosen EL，Blackwell K L，Baker JA，et al.Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy[J].A JR，2003，181(5)：1275-1282.
, http://www.100md.com
[9]Londero V，Bazzocchi M，D el Frate C，et al.Locally advanced breast cancer：comparison of mammography，sonography and M R im aging in evaluation of residual disease in women receiving neoadjuvant chemotherapy[J].Eur Radiol，2004，14(8)：1371-1379.
[10]Uematsu T，Kasami M，Yuen S.Neoadjuvant chemotherapy for breast cancer：correlation between the baseline MR imaging finding and responses to therapy[J].Eur Radiol，2010，20(10)：2315-2322.
, 百拇医药 [11]Loo CE，Tertstra HJ，Rodenhuis S，et al.Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy：initial results[J].AJR Am J Roentgenol，2008，191(5)：1331-1338.
[12]Huang B，Wong C S，Whitcher B，et al.Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma：comparison of semiquantitative and quantitative parameters and correlation with tumour stage[J]. European Radiology，2013，23(6)：1495-1502.
[13]杜永浩，牛剛，杨建.定量动态增强磁共振技术的影响因素分析[J].磁共振成像，2017，8(1)：76-80.
[14]Tudorica A，Oh K Y，Chui S Y，et al.Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI[J].Translational Oncology，2016，9(1)：8., 百拇医药(屈欣然)
[3]Fisher B，Brown A，Mamounas E，et al.Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer：findings from National Surgical Adjuvant Breast and Bowel Project B-18[J].Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology，1997，15(7)：2483-2493.
, 百拇医药
[4]van der H age JA，van de V elde CJ，Julien JP，et al.Preoperative chemotherapy in primary operable breast cancer：results from the European Organization for research and treatment of cancer trial10902[J].JC lin O ncol，2001，19(22)：4224-4237.
[5]Londero V，Bazzocchi M，D elFrate C，et al.Locally advanced breast cancer：comparison of m am m ography，sonography and M R im aging in evaluation of residual disease in women receiving neoadjuvant chemotherapy[J].Eur R adiol，2004，14(8)：1371-1379.
, 百拇医药
[6]Kuhl C K，Mielcareck P，Klaschik S，et al.Dynamic breast MR imaging：are signal intensity time course data useful for differential diagnosis of enhancing lesions[J].Radiology，1999，211(1)：101.
[7]王丽，仁友，蒋涛.乳腺疾病动态增强MRI半定量参数与微血管密度的相关性[J].中国医学影像技术，2007，23(3)：388-392.
[8]Rosen EL，Blackwell K L，Baker JA，et al.Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy[J].A JR，2003，181(5)：1275-1282.
, http://www.100md.com
[9]Londero V，Bazzocchi M，D el Frate C，et al.Locally advanced breast cancer：comparison of mammography，sonography and M R im aging in evaluation of residual disease in women receiving neoadjuvant chemotherapy[J].Eur Radiol，2004，14(8)：1371-1379.
[10]Uematsu T，Kasami M，Yuen S.Neoadjuvant chemotherapy for breast cancer：correlation between the baseline MR imaging finding and responses to therapy[J].Eur Radiol，2010，20(10)：2315-2322.
, 百拇医药 [11]Loo CE，Tertstra HJ，Rodenhuis S，et al.Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy：initial results[J].AJR Am J Roentgenol，2008，191(5)：1331-1338.
[12]Huang B，Wong C S，Whitcher B，et al.Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma：comparison of semiquantitative and quantitative parameters and correlation with tumour stage[J]. European Radiology，2013，23(6)：1495-1502.
[13]杜永浩，牛剛，杨建.定量动态增强磁共振技术的影响因素分析[J].磁共振成像，2017，8(1)：76-80.
[14]Tudorica A，Oh K Y，Chui S Y，et al.Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI[J].Translational Oncology，2016，9(1)：8., 百拇医药(屈欣然)